Podcast

Examining Consumer Cost Sharing and a Precision Benefit Design With Dr Mark Fendrick

Author(s):

Current policies being employed to limit spending can have serious consequences for patients, but a different benefit design approach could present an alternative strategy.

Current policies being employed to limit spending can have serious consequences for patients. In the April issue of The American Journal of Managed Care® (AJMC®), A. Mark Fendrick, MD, co-authored a paper that examined the relationship between consumer cost sharing for branded antidepressants and the initiation of branded therapy among patients who were filling a prescription for a generic medication to treat major depressive disorder.

iTunes: http://apple.co/2eYWTss

TuneIn: http://bit.ly/2gv7iwj

Stitcher: http://bit.ly/2gCqtFg

Read the paper:

Listen above or through one of these podcast services:Cost Sharing and Branded Antidepressant Initiation Among Patients Treated With Generics

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center
Merrill H. Stewart, MD
H. John Beardsley, MBA, and Fauzea Hussain, MPH, sitting for a video interview
Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center
Merrill H. Stewart, MD
Dr CK Wang
Nini Wu, MD, Navista
Jonathan Strober, MD, UCSF Benioff Children's Hospital
Bridgette J. Picou, LVN, ACLPN, The Well Project
Emma Achola-Kothari, PhD
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo